OBJECTIVE: This multicenter, cross-sectional study was conducted to determine the sensitivity and specificity of a 9-item Wearing-off Questionnaire (WOQ-9) compared with assessment by a clinician. METHODS: Patients with a diagnosis of Parkinson's disease (PD) for 5 <or=years, and receiving stable antiparkinsonian therapy for >or=90 days, completed the WOQ-9 before independent evaluation by the physician. RESULTS: One hundred fifty-seven patients reported WO using the WOQ-9; only 79 had been previously diagnosed with WO by a physician. The most frequent items used by physicians to diagnose WO included type of symptoms (69.6%), symptom response (63.3%), and timing of symptom response (58.2%) to medication. Physician assessment of WO and WOQ-9 results corresponded in 76 of 79 cases; physicians disagreed with WO identification in 81 of 157 cases. Sensitivity of the WOQ-9 was 96.2% and specificity was 40.9%. CONCLUSION: The WOQ-9 is a useful screening tool to aid diagnosis of WO in PD patients.
OBJECTIVE: This multicenter, cross-sectional study was conducted to determine the sensitivity and specificity of a 9-item Wearing-off Questionnaire (WOQ-9) compared with assessment by a clinician. METHODS:Patients with a diagnosis of Parkinson's disease (PD) for 5 <or=years, and receiving stable antiparkinsonian therapy for >or=90 days, completed the WOQ-9 before independent evaluation by the physician. RESULTS: One hundred fifty-seven patients reported WO using the WOQ-9; only 79 had been previously diagnosed with WO by a physician. The most frequent items used by physicians to diagnose WO included type of symptoms (69.6%), symptom response (63.3%), and timing of symptom response (58.2%) to medication. Physician assessment of WO and WOQ-9 results corresponded in 76 of 79 cases; physicians disagreed with WO identification in 81 of 157 cases. Sensitivity of the WOQ-9 was 96.2% and specificity was 40.9%. CONCLUSION: The WOQ-9 is a useful screening tool to aid diagnosis of WO in PDpatients.
Authors: A Chan; Y F Cheung; M Au Yeung; J Yeung; T H Chung; K L Tsang; J Chan; C Lau; P Kwan; Sheng-Han Kuo; V Mok Journal: Clin Neurol Neurosurg Date: 2011-04-20 Impact factor: 1.876
Authors: Joaquin A Vizcarra; Álvaro Sánchez-Ferro; Walter Maetzler; Luca Marsili; Lucia Zavala; Anthony E Lang; Pablo Martinez-Martin; Tiago A Mestre; Ralf Reilmann; Jeffrey M Hausdorff; E Ray Dorsey; Serene S Paul; Judith W Dexheimer; Benjamin D Wissel; Rebecca L M Fuller; Paolo Bonato; Ai Huey Tan; Bastiaan R Bloem; Catherine Kopil; Margaret Daeschler; Lauren Bataille; Galit Kleiner; Jesse M Cedarbaum; Jochen Klucken; Aristide Merola; Christopher G Goetz; Glenn T Stebbins; Alberto J Espay Journal: Mov Disord Date: 2019-03-22 Impact factor: 10.338
Authors: Randy Neblett; Howard Cohen; YunHee Choi; Meredith M Hartzell; Mark Williams; Tom G Mayer; Robert J Gatchel Journal: J Pain Date: 2013-03-13 Impact factor: 5.820
Authors: Alexander Storch; Christine B Schneider; Lisa Klingelhöfer; Per Odin; Gerd Fuchs; Wolfgang H Jost; Pablo Martinez-Martin; Rainer Koch; Heinz Reichmann; K Ray Chaudhuri; Georg Ebersbach Journal: J Neural Transm (Vienna) Date: 2015-08-12 Impact factor: 3.575
Authors: Aida Arroyo-Ferrer; Francisco José Sánchez-Cuesta; Yeray González-Zamorano; María Dolores Del Castillo; Carolina Sastre-Barrios; Marcos Ríos-Lago; Juan Pablo Romero Journal: Medicina (Kaunas) Date: 2021-03-26 Impact factor: 2.430
Authors: Emmanuelle Schmitt; Paul Krack; Anna Castrioto; Helene Klinger; Amelie Bichon; Eugénie Lhommée; Pierre Pelissier; Valerie Fraix; Stephane Thobois; Elena Moro; Pablo Martinez-Martin Journal: Mov Disord Clin Pract Date: 2018-03-23